Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow TransplantationMiguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Leukemia & Lymphoma|May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood Advances|January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online toolMatthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypesOwen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
British Journal of Haematology|May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomesSusan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
British Journal of Haematology|March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaRyan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 10, 2018
Anomalous coronary artery originating from the opposite sinus of Valsalva (ACAOS), fractional flow reserve- and intravascular ultrasound-guided management in adult patientsBart W Driesen, Evangeline G Warmerdam, Gert-Jan T Sieswerda, et al.
Blood Advances|June 1, 2023
An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancyFaheem Farooq, Justin S Brandt, Elyce Cardonick, et al.
Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow TransplantationMiguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Leukemia & Lymphoma|May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood Advances|January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online toolMatthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypesOwen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
British Journal of Haematology|May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomesSusan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
British Journal of Haematology|March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaRyan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 10, 2018
Anomalous coronary artery originating from the opposite sinus of Valsalva (ACAOS), fractional flow reserve- and intravascular ultrasound-guided management in adult patientsBart W Driesen, Evangeline G Warmerdam, Gert-Jan T Sieswerda, et al.
Blood Advances|June 1, 2023
An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancyFaheem Farooq, Justin S Brandt, Elyce Cardonick, et al.
Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.
Pageof 26